CNS & Neurological Disorders - Drug Targets
Title:Meet Our Section Editor
Volume: 19 Issue: 5
Author(s): Yumin Luo
Affiliation:
Export Options
About this article
Cite this article as:
Luo Yumin , Meet Our Section Editor, CNS & Neurological Disorders - Drug Targets 2020; 19 (5) . https://dx.doi.org/10.2174/187152731905201012091023
DOI https://dx.doi.org/10.2174/187152731905201012091023 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gastroenterological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Lack of Evidence for Deterioration in Endothelial Function Following Ticagrelor Treatment Cessation
Current Vascular Pharmacology Prediction of Thrombin and Factor Xa Inhibitory Activity with Associative Neural Networks
Current Computer-Aided Drug Design Role of Angiotensin-1-Receptor Blockers In Cardiorenal Disease
Current Drug Therapy Biomedical Imaging in Implantable Drug Delivery Systems
Current Drug Targets Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.
Current Clinical Pharmacology Statins Therapy is Associated with Increased Populations of Early Endothelial Progenitor (CD133+/VEGFR2+) and Endothelial (CD34-/CD133- /VEGFR2+) Cells in Patients with Acute Ischemic Stroke
Current Neurovascular Research Synthesis of Biologically Active Selenium-Containing Molecules From Greener Perspectives
Current Green Chemistry The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High
Current Cardiology Reviews Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease
Current Alzheimer Research Overview of Therapeutic Potential of Rapamycin for Coronary Artery Diseases in the Era of the Drug-Eluting Stent
Vascular Disease Prevention (Discontinued) Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Epigenetics in the Cerebrovascular System: Changing the Code without Altering the Sequence
Current Neurovascular Research Shear Stress-sensitive Carriers for Localized Drug Delivery
Current Pharmaceutical Design “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology An Experience with Delamanid in an XDR TB Case – Case Report
Infectious Disorders - Drug Targets Impact of Matrix Metalloproteinases on Atherosclerosis
Current Drug Targets The Impacts of Non-coding RNAs and N<sup>6</sup>-Methyladenosine on Cancer: Past, Present and Future
Current Cancer Drug Targets